MEP39308A - Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method - Google Patents

Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Info

Publication number: MEP39308A
Authority: ME; Montenegro
Prior art keywords: substance; subcutaneous dose; fsh; substances; amount equivalent
Prior art date: 2002-06-07

Application number

MEP-393/08A

Other languages

Bosnian (bs)

English (en)

Croatian (hr)

Inventor

Evert Johannes Bunschoten

Bennink Herman Jan Tijmen Coelingh

Original Assignee

Ares Trading S A Chateau De Vaumarcus

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-07

Filing date

2003-06-06

Publication date

2011-02-10

2003-06-06 Application filed by Ares Trading S A Chateau De Vaumarcus filed Critical Ares Trading S A Chateau De Vaumarcus

2011-02-10 Publication of MEP39308A publication Critical patent/MEP39308A/xx

Links

238000000034 method Methods 0.000 title abstract 5
206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 title 1
239000000126 substance Substances 0.000 abstract 7
102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 4
108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 4
229940028334 follicle stimulating hormone Drugs 0.000 abstract 4
238000007920 subcutaneous administration Methods 0.000 abstract 4
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 abstract 2
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 2
GJNXBNATEDXMAK-PFLSVRRQSA-N ganirelix Chemical compound C([C@@H](C(=O)N[C@H](CCCCN=C(NCC)NCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 GJNXBNATEDXMAK-PFLSVRRQSA-N 0.000 abstract 2
229960003794 ganirelix Drugs 0.000 abstract 2
108700032141 ganirelix Proteins 0.000 abstract 2
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 abstract 2
229940121381 gonadotrophin releasing hormone (gnrh) antagonists Drugs 0.000 abstract 2
229940035638 gonadotropin-releasing hormone Drugs 0.000 abstract 2
230000029849 luteinization Effects 0.000 abstract 2
230000021121 meiosis Effects 0.000 abstract 2
230000002611 ovarian Effects 0.000 abstract 2
210000002700 urine Anatomy 0.000 abstract 2
206010071083 Luteinising hormone deficiency Diseases 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000008217 follicular development Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
230000002028 premature Effects 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Pregnancy & Childbirth (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MEP-393/08A 2002-06-07 2003-06-06 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method MEP39308A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02077221		2002-06-07
PCT/NL2003/000370 WO2003103770A2 (en)	2002-06-07	2003-06-06	Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Publications (1)

Publication Number	Publication Date
MEP39308A true MEP39308A (en)	2011-02-10

Family

ID=29724462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-393/08A MEP39308A (en)	2002-06-07	2003-06-06	Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Country Status (21)

Country	Link
US (1)	US7815912B2 (de)
EP (1)	EP1511537B1 (de)
JP (1)	JP2005530818A (de)
KR (1)	KR20050058285A (de)
CN (1)	CN1684737A (de)
AU (1)	AU2003274929B2 (de)
BR (1)	BR0305033A (de)
CA (1)	CA2488719A1 (de)
EA (1)	EA009371B1 (de)
ES (1)	ES2399962T3 (de)
IL (1)	IL165522A0 (de)
IS (1)	IS7586A (de)
ME (1)	MEP39308A (de)
MX (1)	MXPA04012246A (de)
NO (1)	NO20045304L (de)
NZ (1)	NZ536984A (de)
PL (1)	PL373991A1 (de)
RS (1)	RS105004A (de)
UA (1)	UA81251C2 (de)
WO (1)	WO2003103770A2 (de)
ZA (1)	ZA200409857B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE473746T1 (de) *	2007-01-08	2010-07-15	Pantarhei Bioscience Bv	Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
BR112014001274A2 (pt)	2011-07-18	2017-04-18	Arts Biologics As	composto de hormônio luteinizante, e, composição farmacêutica
US9216037B2 (en)	2013-06-21	2015-12-22	Previvo Genetics, Llc	Uterine lavage for embryo retrieval
US20150272622A1 (en)	2011-12-22	2015-10-01	Previvo Genetics, Llc	Recovery and processing of human embryos formed in vivo
US9282995B2 (en) *	2011-12-22	2016-03-15	Previvo Genetics, Llc	Recovery and processing of human embryos formed in vivo
UA127283C2 (uk)	2016-07-21	2023-07-12	Обсева С.А.	Спосіб застосування антагоніста окситоцину для сприяння імплантації ембріона і запобігання викидню
US20220323410A1 (en)	2019-09-03	2022-10-13	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
WO2021160597A1 (en)	2020-02-10	2021-08-19	ObsEva S.A.	Biomarkers for oxytocin receptor antagonist therapy
WO2026018221A1 (en)	2024-07-18	2026-01-22	ReproNovo SA	Crystalline compositions for improving embryo implantation and methods of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0788799A3 (de) *	1996-02-07	1998-10-21	ASTA Medica Aktiengesellschaft	LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
CN1199642A (zh) *	1997-05-16	1998-11-25	Asta药物股份公司	治疗不育症的lhrh－拮抗剂
ATE302018T1 (de)	1997-06-20	2005-09-15	Akzo Nobel Nv	Gonadotropin releasing hormon antagonist
CZ301912B6 (cs) *	1998-04-23	2010-07-28	Zentaris Ivf Gmbh	Lécivo na lécení neplodnosti nitrodeložní inseminací
CN1353617A (zh) *	1999-02-24	2002-06-12	诺沃挪第克公司	不孕症的治疗
WO2001000227A1 (en) *	1999-06-23	2001-01-04	Akzo Nobel N.V.	Gonadotropin releasing hormone antagonist
US20030092628A1 (en) *	1999-06-23	2003-05-15	De Greef Henrik Johan Matthieu Maria	Gonadotropin releasing hormone antagonist
DE60231892D1 (de) *	2001-09-12	2009-05-20	Serono Lab	Verwendung von lh für die kontrollierte ovarielle hyperstimulation
AU2002358346A1 (en)	2001-12-21	2003-07-15	Pantarhei Bioscience B.V.	Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

2003
- 2003-06-06 US US10/517,028 patent/US7815912B2/en not_active Expired - Fee Related
- 2003-06-06 NZ NZ536984A patent/NZ536984A/en unknown
- 2003-06-06 EA EA200401619A patent/EA009371B1/ru not_active IP Right Cessation
- 2003-06-06 JP JP2004510888A patent/JP2005530818A/ja active Pending
- 2003-06-06 UA UAA200500168A patent/UA81251C2/uk unknown
- 2003-06-06 CN CNA038183900A patent/CN1684737A/zh active Pending
- 2003-06-06 PL PL03373991A patent/PL373991A1/xx not_active Application Discontinuation
- 2003-06-06 ES ES03741621T patent/ES2399962T3/es not_active Expired - Lifetime
- 2003-06-06 ME MEP-393/08A patent/MEP39308A/xx unknown
- 2003-06-06 AU AU2003274929A patent/AU2003274929B2/en not_active Ceased
- 2003-06-06 KR KR1020047019890A patent/KR20050058285A/ko not_active Ceased
- 2003-06-06 BR BR0305033-5A patent/BR0305033A/pt not_active IP Right Cessation
- 2003-06-06 RS YUP-1050/04A patent/RS105004A/sr unknown
- 2003-06-06 CA CA002488719A patent/CA2488719A1/en not_active Abandoned
- 2003-06-06 MX MXPA04012246A patent/MXPA04012246A/es unknown
- 2003-06-06 EP EP03741621A patent/EP1511537B1/de not_active Expired - Lifetime
- 2003-06-06 WO PCT/NL2003/000370 patent/WO2003103770A2/en not_active Ceased
2004
- 2004-12-02 IL IL16552204A patent/IL165522A0/xx unknown
- 2004-12-03 NO NO20045304A patent/NO20045304L/no not_active Application Discontinuation
- 2004-12-03 IS IS7586A patent/IS7586A/is unknown
- 2004-12-06 ZA ZA200409857A patent/ZA200409857B/xx unknown

Also Published As

Publication number	Publication date
CN1684737A (zh)	2005-10-19
NZ536984A (en)	2008-01-31
US7815912B2 (en)	2010-10-19
EA200401619A1 (ru)	2005-06-30
UA81251C2 (en)	2007-12-25
BR0305033A (pt)	2004-11-09
NO20045304L (no)	2005-02-07
IS7586A (is)	2004-12-03
EP1511537A2 (de)	2005-03-09
RS105004A (sr)	2007-02-05
WO2003103770A3 (en)	2004-04-22
ZA200409857B (en)	2006-02-22
ES2399962T3 (es)	2013-04-04
PL373991A1 (en)	2005-09-19
MXPA04012246A (es)	2005-04-08
KR20050058285A (ko)	2005-06-16
CA2488719A1 (en)	2003-12-18
US20050235374A1 (en)	2005-10-20
IL165522A0 (en)	2006-01-15
EA009371B1 (ru)	2007-12-28
AU2003274929A1 (en)	2003-12-22
WO2003103770A2 (en)	2003-12-18
AU2003274929B2 (en)	2008-04-10
EP1511537B1 (de)	2012-11-21
JP2005530818A (ja)	2005-10-13

Publication	Publication Date	Title
Schneider et al.	1970	Estradiol and the neuroendocrine control of LH release in vitro
Huirne et al.	2006	Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study
MEP39308A (en)	2011-02-10	Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
AR011217A1 (es)	2000-08-02	UN PÉPTIDO ANTAGONISTA DE GNRH, UNA COMPOSICIoN FARMACÉUTICA PARA INHIBIR LA SECRECIoN DE GONADOTROPINAS EN MAMíFEROS Y UN COMPUESTO INTERMEDIARIO PARA PREPARAR UN PÉPTIDO ANTAGONISTA DE GNRH.
Wilcox et al.	2005	Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies
Thomas et al.	2012	Principles of endocrine pharmacology
RU2005136527A (ru)	2006-07-27	Унитарная комбинация fsh и hcg
KR950703359A (ko)	1995-09-20	임신치료를 위한 파라소면(parathormone), 그 생물학적 활성 프래그먼트(fragment) 및 관련 펩티드(peptide)의 용도
Findeklee et al.	2023	Cetrorelix in reproductive medicine
Tur-Kaspa et al.	2009	GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology
Reichman et al.	2014	GnRH antagonist-based protocols for in vitro fertilization
EA200200801A1 (ru)	2003-02-27	Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
EA200400591A1 (ru)	2004-10-28	СПОСОБ ВВЕДЕНИЯ ПЕПТИДА ТИМОЗИН α1
WO2005018657A3 (en)	2005-04-07	NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
WO2005019457A3 (en)	2005-08-11	NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
WO1990014839A1 (en)	1990-12-13	A process for treating infertility and an agent for use in the process
KR20030051828A (ko)	2003-06-25	에스트로겐 의존성 질환의 병용 치료법
Mills et al.	1983	Is the postovulatory release of follicle-stimulating hormone in the rabbit mediated by luteinizing hormone-releasing hormone?
BR9611760A (pt)	1999-10-05	Novos antagonistas lh-rh com efeito aperfeiçoado
Bretzlaff	1987	Physiology and pharmacology of the postpartum cow and retained fetal membranes
Tarhan et al.	1995	Oxytocin-induced contractions of the rabbit corpus cavernosum
Daya	1999	GnRH antagonists in assisted reproduction
Casper	1994	successive doses of GnRH agonists throughout the human menstrual cycle
Engel et al.	2003	Luteinizing hormone-releasing hormone antagonists in gynecology
CN1199642A (zh)	1998-11-25	治疗不育症的lhrh－拮抗剂